General Session
 

⬇️ KEYNOTE | Assessing the Global Shift 
in Investigative Sites​
Kenneth Getz, Tufts CSDD, Tufts University School of Medicine

⬇️ Show Up, Stay In, Come Back: The Untapped Economics of Patient Experience
Jonathan Moshinsky, Stitch, and Carlos Orantes, Alcanza Clinical Research
 

SOAPBOX PRESENTATIONS

⬇️ Trially | Kyle McCallister

⬇️ Transformative Pharmaceutical Solutions (TPS) | Xoli Belgrave

⬇️ mdgroup | LaQuinta Jernigan

⬇️ Double Blind Bio | Shruti Tibrewala

⬇️ myTomorrows | Dennis Akkaya

⬇️ Delfa | Tom Farrand

⬇️ Slope | Taylor Walber

Track 1 (3:45pm - 5:50pm)

⬇️ Building Supply‑Chain‑Like Partnerships Between Sponsors and Site Organizations
Jim Kremidas, AMRC, Sean Cunningham, Takeda, Sean Stanton, K2 Medical Research, Mary Margaret Williams, Merck Research Labs, Paul Evans, Velocity Clinical Research

⬇️ Designing with Sites First: Reducing Trial Burden Through Early Collaboration
Rebecca Sayers, IQVIA

⬇️ How Sponsor-Site Collaboration Delivered a Scalable Community Engagement Model in Alzheimer’s Research
Raul Rubio Moreno, Sun Valley Research Center

Track 2 (3:45pm - 5:50pm)

⬇️ How Scarcity Inverts the Traditional Sponsor-Site Partnership Dynamic and the Impact on Patient Enrollment
Sonia Prashar, AIM Trials

⬇️ Aligning Site Tech Needs with Sponsor Strategy — Findings from Tufts CSDD and Evinova
Jill Bell, Evinova

⬇️ Moving Trials Forward: Inside the Merck and WCG Partnership that Unblocks Bottlenecks and Empowers Sites
Kari Lotsberg, WCG, and Kate Boneck, Merck